Today on DrugResearcher.com   Keeping sugar-free key to neuron health Viagra could cause hearing loss EU drug regulations not good enough, says report Pfizer partners in shock after surprise Exubera exit Promega speeds up DNA-protein interaction analysis

Related Industry News   King trims its court following Altace about-turn Topical Voltaren Gel gets the nod Capacity doubled for fishy pharmaceutical Pharma outsourcing: people on the move

Breaking News on Drug Discovery
Daily  Monday 22 October 2007		Forward to a colleague

	Product Brochure High precision optical profiling of liquid drops enhances drug discovery Whether you are characterizing the uptake of active drug substances or controlling the quality of packaging materials, contact angle provides a quick, easy and sensitive measure of quality and cleanliness in research, QC and process control... Click Here Access Full Stories Keeping sugar-free key to neuron health Scientists have discovered how neurons keep themselves sugar-free and healthy, a process that must be upheld to prevent the onset of several neurodegenerative diseases, including a fatal form of epilepsy... Read Viagra could cause hearing loss The earth may move and the heavens may shake but drug regulators now think Viagra could also make you go deaf... Read EU drug regulations not good enough, says report The European Medicines Agency is prejudiced in favour of big pharma and EU drug regulations need an overhaul, a new report says... Read Pfizer partners in shock after surprise Exubera exit We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find... Read Promega speeds up DNA-protein interaction analysis Promega has launched a new method of isolating the DNA sequences that bind to proteins that removes the need to generate specific antibodies used in traditional ChIP experiments... Read
	All News Headlines for: October | September | August
	Related Industry News King trims its court following Altace about-turn King Pharmaceuticals last week announced that it would be cutting 20 per cent of its workforce after the US Court of Appeals reversed a previous court ruling and invalidated a patent covering the firm's blood pressure... Read Topical Voltaren Gel gets the nod Novartis has received US approval for its osteoporosis pain gel - the first for a topical prescription treatment for the indication... Read Capacity doubled for fishy pharmaceutical Norwegian firm Pronova BioPharma announced this morning that it is to double manufacturing capacity for its marine-derived active pharmaceutical ingredient (API), following increased demand for its omega-3 based... Read Pharma outsourcing: people on the move Icon, PPD, Chiltern, Kendle, Omnicare and Aesica have all had people on the move in the world of pharmaceutical outsourcing... Read Weekly Comment 'We are not anti-Asia' says EU chemicals body There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However, despite having recently established a dedicated 'China Taskforce', a major EU chemicals consortium insists that it has nothing against the region or its manufacturers. Read Previous Headlines Discarded body parts used to cut animal testing A team of US scientists have used typically discarded body parts to create a 'joint in a test tube', which they can use to test arthritis drugs instead of using animals... Read Aspirin won't protect women from a broken heart While aspirin has been found to reduce the risk of heart attack by a quarter, recent research has found that women are less likely to benefit from the drug than men... Read Study your rats so the results don't bite New research has shown that even if laboratory rats are genetically identical they can still develop distinct metabolic profiles that could skew drug toxicity and metabolism studies... Read Drugs that prevent diabetes in obese people on horizon Although obesity dramatically increases the risk of developing Type II diabetes, nobody knew why until researchers found a protein that links the two diseases, opening up the possibility of developing drugs that... Read Pfizer abandons ship as Exubera sinks Pfizer revealed today that it is abandoning its once-touted blockbuster Exubera, ending months of speculation as to whether the fledging world-first inhalable insulin would sink or swim in the fierce waters of... Read Technical / White Papers, Case studies, Web casts Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers DAICEL chiral chromatography products - Company Profile Rapid HPLC method development with ChromSword®Auto software - Product Presentation Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com